SBH
IRWD icon

Segall Bryant & Hamill’s Ironwood Pharmaceuticals IRWD Stock Holding History

Segall Bryant & Hamill’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$976K Buy
+278,201
New +$1.14M 0.01% 509

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Segall Bryant & Hamill's IRWD Position: Q1 2026 in Review

Segall Bryant & Hamill opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 278,201 shares worth $976K. The stake represents 0.01% of the portfolio and ranks #509 among its holdings.

226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Segall Bryant & Hamill held 278,201 shares of Ironwood Pharmaceuticals worth $976K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Segall Bryant & Hamill position in Q1 2026.
  • Ironwood Pharmaceuticals made up 0.01% of Segall Bryant & Hamill's portfolio in Q1 2026, its #509 holding.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.